The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000

Ricardo Azziz, Paul Saenger

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Clinical hyperandrogenism, in particular polycystic ovary syndrome (PCOS), affects 4-7% of women of reproductive age, making it one of the most common human reproductive endocrinological abnormalities. However, our understanding of the developmental aspects of these disorders remains limited. The Second International Symposium on the Developmental Aspects of Androgen Excess (Toronto, Canada, 20 June 2000) was held with the purpose of fostering greater investigative communication, consensus and focus. It was felt that a better understanding of PCOS phenotypes was needed; that an aggressive attempt should be made to continue to expand the molecular genetic studies of the disorder; that research into the role and mechanism(s) underlying the associated defects in insulin action and signaling should be continued; that longitudinal studies, particularly those focusing on the role of intrauterine stress and malnutrition, and premature adrenarche, on the development of PCOS were warranted; and that an improved understanding of the molecular defects in steroidogenesis present in PCOS is needed.

Original languageEnglish (US)
Pages (from-to)338-340
Number of pages3
JournalTrends in Endocrinology and Metabolism
Volume11
Issue number8
DOIs
StatePublished - Jan 1 2000

Fingerprint

Polycystic Ovary Syndrome
Androgens
Canada
Adrenarche
Hyperandrogenism
Inborn Genetic Diseases
Foster Home Care
Malnutrition
Longitudinal Studies
Molecular Biology
Consensus
Communication
Insulin
Phenotype
Research

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000. / Azziz, Ricardo; Saenger, Paul.

In: Trends in Endocrinology and Metabolism, Vol. 11, No. 8, 01.01.2000, p. 338-340.

Research output: Contribution to journalArticle

@article{1d7944d4a7e94c60a9a65dfee89d06e4,
title = "The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000",
abstract = "Clinical hyperandrogenism, in particular polycystic ovary syndrome (PCOS), affects 4-7{\%} of women of reproductive age, making it one of the most common human reproductive endocrinological abnormalities. However, our understanding of the developmental aspects of these disorders remains limited. The Second International Symposium on the Developmental Aspects of Androgen Excess (Toronto, Canada, 20 June 2000) was held with the purpose of fostering greater investigative communication, consensus and focus. It was felt that a better understanding of PCOS phenotypes was needed; that an aggressive attempt should be made to continue to expand the molecular genetic studies of the disorder; that research into the role and mechanism(s) underlying the associated defects in insulin action and signaling should be continued; that longitudinal studies, particularly those focusing on the role of intrauterine stress and malnutrition, and premature adrenarche, on the development of PCOS were warranted; and that an improved understanding of the molecular defects in steroidogenesis present in PCOS is needed.",
author = "Ricardo Azziz and Paul Saenger",
year = "2000",
month = "1",
day = "1",
doi = "10.1016/S1043-2760(00)00319-2",
language = "English (US)",
volume = "11",
pages = "338--340",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - The Second International Symposium on the Developmental Aspects of Androgen Excess, Toronto, Canada, 20 June 2000

AU - Azziz, Ricardo

AU - Saenger, Paul

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Clinical hyperandrogenism, in particular polycystic ovary syndrome (PCOS), affects 4-7% of women of reproductive age, making it one of the most common human reproductive endocrinological abnormalities. However, our understanding of the developmental aspects of these disorders remains limited. The Second International Symposium on the Developmental Aspects of Androgen Excess (Toronto, Canada, 20 June 2000) was held with the purpose of fostering greater investigative communication, consensus and focus. It was felt that a better understanding of PCOS phenotypes was needed; that an aggressive attempt should be made to continue to expand the molecular genetic studies of the disorder; that research into the role and mechanism(s) underlying the associated defects in insulin action and signaling should be continued; that longitudinal studies, particularly those focusing on the role of intrauterine stress and malnutrition, and premature adrenarche, on the development of PCOS were warranted; and that an improved understanding of the molecular defects in steroidogenesis present in PCOS is needed.

AB - Clinical hyperandrogenism, in particular polycystic ovary syndrome (PCOS), affects 4-7% of women of reproductive age, making it one of the most common human reproductive endocrinological abnormalities. However, our understanding of the developmental aspects of these disorders remains limited. The Second International Symposium on the Developmental Aspects of Androgen Excess (Toronto, Canada, 20 June 2000) was held with the purpose of fostering greater investigative communication, consensus and focus. It was felt that a better understanding of PCOS phenotypes was needed; that an aggressive attempt should be made to continue to expand the molecular genetic studies of the disorder; that research into the role and mechanism(s) underlying the associated defects in insulin action and signaling should be continued; that longitudinal studies, particularly those focusing on the role of intrauterine stress and malnutrition, and premature adrenarche, on the development of PCOS were warranted; and that an improved understanding of the molecular defects in steroidogenesis present in PCOS is needed.

UR - http://www.scopus.com/inward/record.url?scp=0033793282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033793282&partnerID=8YFLogxK

U2 - 10.1016/S1043-2760(00)00319-2

DO - 10.1016/S1043-2760(00)00319-2

M3 - Article

C2 - 11273567

AN - SCOPUS:0033793282

VL - 11

SP - 338

EP - 340

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 8

ER -